ExoAtlet, RVC Biofund Portfolio company, commences clinical trials of exoskeletons

ExoAtlet, RVC Biofund Portfolio company, invites volunteers with lower paraparesis to pilot medical exoskeletons for rehabilitation as part of clinical studies.

On June 28, 2016 ExoAtlet was registered as medical device in Rozdrav (its registration number РЗН 2016/4360)

On 1st of July RNRMU named after N.I. Pirogov started clinical trials of ExoAtlet® exoskeletons. It was the first round of the grant awarded by Skolkovo. The study will engage 24 pilots (volunteers) who have traumas of thoracic and lumbar spine or suffer from locomotion disorder but who are not completely paralysed. The study sets the objective of conducting comparative analysis of exoskeletons and classical methods of robotic mechanotherapy which have already been used for rehabilitation activities.

Similar robotic facilities of foreign origin can be seen in several Russian clinics , but their exorbitant price is inaccessible to the public.

12 pilots will take a course of 12 trainings based on functional electro myostimulation and individual physiotherapy. Other 12 participants will take a course based on standard methods of mechanotherapy and individual physiotherapy. The duration of rehabilitation course is 15 days for each patient

ExoAtlet invites volunteers with lower paraparesis to pilot medical exoskeletons for rehabilitation as part of clinical studies. For terms and conditions or feedback address, please follow the link http://www.exoatlet.ru. In 2014 ExoAtlet reached the final of GenerationS Federal Competition organized by Russian Venture Company . In November 2015 Moscow Seed Fund jointly with RVC Biofund invested 16 million rubles in ExoAtlet company.